Greenbrook TMS Inc. (GBNH)

Market Cap	11.53M
Revenue (ttm)	80.08M
Net Income (ttm)	-68.03M
Shares Out	42.77M
EPS (ttm)	-2.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,002
Open	0.240
Previous Close	0.270
Day's Range	0.240 - 0.270
52-Week Range	0.235 - 4.380
Beta	1.70
Analysts	Buy
Price Target	1.88 (+597.59%)
Earnings Date	Nov 7, 2023

About GBNH

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delawa...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2011
• Employees: 484
• Stock Exchange: NASDAQ
• Ticker Symbol: GBNH

Financial Performance

In 2022, Greenbrook TMS's revenue was $69.10 million, an increase of 32.39% compared to the previous year's $52.20 million. Losses were -$61.73 million, 149.4% more than in 2021.

Analyst Forecast

According to 2 analysts, the average rating for GBNH stock is "Buy." The 12-month stock price forecast is $1.88, which is an increase of 597.59% from the latest price.

Price Target

$1.88

(597.59% upside)

Analyst Consensus: Buy